Tag: Wandercraft
Wandercraft has officially launched Eve exoskeleton
September 21, 2026HME News Staff
NEW YORK – Wandercraft has announced the U.S. commercial launch of Eve, making it the world’s first self-balancing personal exoskeleton cleared by the U.S. Food and Drug Administration (FDA), the company says. The launch makes hands-free upright mobility available to eligible wheelchair users living with spinal cord injuries at any level who can manually operate the device’s controller. “FDA clearance showed that Eve was ready to move forward; today is about making it a reality...
Wandercraft announces FDA clearance for personal exoskeleton
August 12, 2026HME News Staff
NEW YORK – Wandercraft has today that the U.S. Food and Drug Administration (FDA) has granted clearance for Eve, its personal self-balancing exoskeleton designed to support upright mobility in everyday life. For eligible wheelchair users, the clearance opens new possibilities beyond rehabilitation, bringing hands-free upright mobility into ordinary moments, the company says. “FDA clearance of Eve marks one of the most important moments in Wandercraft’s history and a significant...
NSM to become exclusive CRT distribution partner for emerging personal exoskeleton
June 29, 2026HME News Staff
NASHVILLE, Tenn. – National Seating & Mobility (NSM) and Wandercraft have entered a commercial partnership to prepare for future access to Eve, Wandercraft’s self-balancing personal exoskeleton designed for home use. Eve is currently under regulatory review by the U.S. Food and Drug Administration (FDA), with an anticipated launch in summer 2026, pending clearance. “Robotics and physical AI are redefining what’s possible for people with complex mobility needs,” said...